pharma
dog
News
when
Latest
Archive
by source
All Sources
Sources Page
Jobs
department
Clinical
Regulatory
Medical Affairs
Commercial
R&D / Discovery
Biostatistics / Data
Manufacturing / CMC
Market Access
therapeutic area
Oncology
Immunology
Neuroscience
Cardiovascular
Metabolic
Rare Disease
Infectious Disease
location & type
Remote Only
US Only
California
Massachusetts
Internships
Phase 3 Roles
All Jobs →
◐
Sign In
Subscribe
🐶
home
jobs
news
search
the cabinet
Drugs
8,127
products tracked ·
1,831
matching
★ save view
↓
export CSV
search
phase
all
Marketed
Phase 3
Phase 2
Phase 1
Preclinical
sort
catalysts
recent
name
therapeutic area
all
Oncology
1831
Infectious Disease
718
Cardiology
425
Pulmonology
396
Immunology
371
Ophthalmology
368
Dermatology
300
Women's Health
131
view
list
cards
Marketed
tucatinib
Tukysa (tucatinib)
Metastatic Colorectal Cancer
Seagen Inc
Phase 2
tucidinostat
tucidinostat
Metastatic Melanoma
HUYA Bioscience International LLC
Phase 2
tulmimetostat
tulmimetostat
Endometrial Cancer
$NVS
NOVARTIS AG
Phase 2
← prev
page 60 of 62
next →
Pain
89
Neurology
1
tuspetinib
tuspetinib
Acute Myelocytic Leukemia (AML, Acute Myeloblastic Leukemia)
$APTOF
Aptose Biosciences Inc.
Phase 2
ulenistamab
ulenistamab [INN]
Metastatic Pancreatic Cancer
Prestige BioPharma Ltd
Preclinical
ulodesine
ulodesine
Acute Lymphocytic Leukemia (ALL, Acute Lymphoblastic Leuk…
Helix BioPharma Corp
Phase 2
umitrelimorgene autodencel
umitrelimorgene autodencel [INN]
Glioblastoma Multiforme (GBM)
Immunomic Therapeutics Inc
Phase 2
utidelone
utidelone [INN]
Breast Cancer
BioStar Pharmaceuticals Inc
Phase 2
uzatresgene autoleucel
uzatresgene autoleucel
Ovarian Cancer
US WorldMeds LLC
Phase 2
vabametkib
vabametkib [INN]
Non-Small Cell Lung Cancer
Abion Inc
Phase 3
vactosertib
vactosertib [INN]
Metastatic Colorectal Cancer
MedPacto Inc
Phase 2
valemetostat
valemetostat [INN]
Non-Small Cell Lung Cancer
Daiichi Sankyo Co Ltd
Marketed
valrubicin
Valstar (valrubicin)
Bladder Carcinoma
Endo Pharmaceuticals Inc
Phase 2
vamotinib
vamotinib [INN]
Chronic Myelocytic Leukemia (CML, Chronic Myeloid Leukemia)
Fusion Pharmaceuticals Inc
Phase 1
varsetatug masetecan
varsetatug masetecan [INN]
Epithelial Tumor
$CTMX
CytomX Therapeutics, Inc.
Phase 2
vebreltinib DR
vebreltinib
Glioblastoma Multiforme (GBM)
$APLM
Apollomics Inc.
Phase 3
velzatinib
velzatinib [INN]
Gastrointestinal Stromal Tumor (GIST)
$GSK
GSK plc
Marketed
vemurafenib
Zelboraf (vemurafenib)
Hairy Cell Leukemia
F. Hoffmann-La Roche Ltd
Phase 2
vemzatatug vedotin
vemzatatug vedotin[INN]
Refractory Multiple Myeloma
$AZN
ASTRAZENECA PLC
Phase 2
venadaparib
venadaparib [INN]
Gastric Cancer
Idience Co Ltd
Phase 2
vepafestinib
vepafestinib [INN]
Non-Small Cell Lung Cancer
Helsinn Healthcare SA
pre_registration
vepdegestrant
vepdegestrant
Human Epidermal Growth Factor Receptor 2 Negative Breast…
$ARVN
ARVINAS, INC.
Phase 2
vididencel
vididencel [INN]
Acute Myelocytic Leukemia (AML, Acute Myeloblastic Leukemia)
Mendus AB
Phase 2
vilastobart
vilastobart
Cervical Cancer
$XLO
Xilio Therapeutics, Inc.
Marketed
vimseltinib
Romvimza (vimseltinib)
Graft Versus Host Disease (GVHD)
Ono Pharmaceutical Co Ltd
Marketed
vinblastine sulfate
Vinblastine Sulfate
Letterer-Siwe Disease (Multifocal and Multisystemic (Diss…
Fresenius Kabi USA LLC
Phase 2
vinorelbine tartrate
Vinorelbine Tartrate
Soft Tissue Sarcoma
Taiwan Liposome Co Ltd
Marketed
vismodegib
Erivedge (vismodegib)
Basal Cell Carcinoma (Basal Cell Epithelioma)
Genentech Inc
Phase 1
vispacabtagene regedleucel
vispacabtagene regedleucel
B-Cell Non-Hodgkin Lymphoma
$CRBU
Caribou Biosciences, Inc.
Phase 2
visugromab
visugromab
Metastatic Hepatocellular Carcinoma (HCC)
Catalym GmbH
